Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

Daphne W. Bell, Jennifer M. Varley, Tara E. Szydlo, Deborah H. Kang, Doke C R Wahrer, Kristen E. Shannon, Marcie Lubratovich, Sigitas J. Verselis, Kurt J. Isselbacher, Joseph F. Fraumeni, Julian M. Birch, Frederick P. Li, Judy E. Garber, Daniel A. Haber

Research output: Contribution to journalArticlepeer-review


The hCHK2 gene encodes the human homolog of the yeast Cds1 and Rad53 G2 checkpoint kinases, whose activation in response to DNA damage prevents cellular entry into mitosis. Here, it is shown that heterozygous germ line mutations in hCHK2 occur in Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in the TP53 gene. These observations suggest that hCHK2 is a tumor suppressor gene conferring predisposition to sarcoma, breast cancer, and brain tumors, and they also provide a link between the central role of p53 inactivation in human cancer and the well-defined G2 checkpoint in yeast.
Original languageEnglish
Pages (from-to)2528-2531
Number of pages3
Issue number5449
Publication statusPublished - 24 Dec 1999


Dive into the research topics of 'Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome'. Together they form a unique fingerprint.

Cite this